DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $407,629 | -37.0% | 1,643 | -39.0% | 0.01% | -30.8% |
| Q2 2023 | $646,800 | -3.7% | 2,695 | +1.2% | 0.01% | 0.0% |
| Q1 2023 | $671,435 | -28.2% | 2,664 | -24.4% | 0.01% | -27.8% |
| Q4 2022 | $935,341 | -71.8% | 3,524 | -72.5% | 0.02% | -72.7% |
| Q3 2022 | $3,314,000 | -65.6% | 12,829 | -66.2% | 0.07% | -62.3% |
| Q2 2022 | $9,633,000 | -62.0% | 37,993 | -56.0% | 0.18% | -53.9% |
| Q1 2022 | $25,343,000 | -24.4% | 86,394 | -15.2% | 0.38% | -11.4% |
| Q4 2021 | $33,521,000 | -33.1% | 101,881 | -38.1% | 0.43% | -34.5% |
| Q3 2021 | $50,136,000 | -8.6% | 164,679 | -19.4% | 0.66% | +4.6% |
| Q2 2021 | $54,824,000 | +27.2% | 204,292 | +6.7% | 0.63% | +26.5% |
| Q1 2021 | $43,098,000 | +17.1% | 191,476 | +15.6% | 0.50% | +18.4% |
| Q4 2020 | $36,805,000 | +22.7% | 165,678 | +19.0% | 0.42% | +16.4% |
| Q3 2020 | $29,986,000 | +37.6% | 139,249 | +13.0% | 0.36% | +39.7% |
| Q2 2020 | $21,786,000 | +30.2% | 123,199 | +1.9% | 0.26% | +15.8% |
| Q1 2020 | $16,734,000 | -59.7% | 120,897 | -55.4% | 0.22% | -47.8% |
| Q4 2019 | $41,565,000 | -33.5% | 270,815 | -37.4% | 0.42% | -33.2% |
| Q3 2019 | $62,483,000 | +0.8% | 432,609 | -0.3% | 0.64% | -1.9% |
| Q2 2019 | $61,995,000 | +4.2% | 433,768 | -3.7% | 0.65% | +0.6% |
| Q1 2019 | $59,495,000 | +12.0% | 450,645 | -12.5% | 0.64% | -8.3% |
| Q4 2018 | $53,128,000 | -15.7% | 515,197 | -11.2% | 0.70% | -4.7% |
| Q3 2018 | $63,030,000 | +10.8% | 580,052 | +0.6% | 0.74% | +5.3% |
| Q2 2018 | $56,905,000 | +7.2% | 576,650 | +6.4% | 0.70% | +2.6% |
| Q1 2018 | $53,062,000 | +2.9% | 541,936 | -2.5% | 0.68% | -0.3% |
| Q4 2017 | $51,590,000 | +13.2% | 555,796 | +4.7% | 0.68% | +11.9% |
| Q3 2017 | $45,556,000 | +19.9% | 531,073 | +17.9% | 0.61% | +13.8% |
| Q2 2017 | $38,010,000 | +19.1% | 450,403 | +20.8% | 0.54% | +16.5% |
| Q1 2017 | $31,902,000 | -10.7% | 372,987 | -18.7% | 0.46% | -8.3% |
| Q4 2016 | $35,718,000 | -3.6% | 458,849 | -2.9% | 0.50% | -8.9% |
| Q3 2016 | $37,055,000 | +34.1% | 472,692 | +72.8% | 0.55% | +20.8% |
| Q2 2016 | $27,634,000 | +34.7% | 273,594 | +26.5% | 0.46% | +12.8% |
| Q1 2016 | $20,518,000 | +24.3% | 216,292 | +21.7% | 0.40% | +10.7% |
| Q4 2015 | $16,511,000 | +45.5% | 177,756 | +33.5% | 0.37% | +31.7% |
| Q3 2015 | $11,345,000 | +60.4% | 133,137 | +61.1% | 0.28% | +68.5% |
| Q2 2015 | $7,073,000 | +0.8% | 82,633 | 0.0% | 0.16% | -1.8% |
| Q1 2015 | $7,016,000 | -0.9% | 82,633 | 0.0% | 0.17% | -14.3% |
| Q4 2014 | $7,083,000 | +12.8% | 82,633 | 0.0% | 0.20% | +0.5% |
| Q3 2014 | $6,279,000 | -41.6% | 82,633 | -39.4% | 0.20% | +14.7% |
| Q2 2014 | $10,744,000 | +113.6% | 136,458 | +103.4% | 0.17% | -0.6% |
| Q1 2014 | $5,031,000 | +68.1% | 67,076 | +73.1% | 0.17% | +64.4% |
| Q4 2013 | $2,992,000 | +18.7% | 38,745 | +6.6% | 0.10% | +15.6% |
| Q3 2013 | $2,520,000 | +9.5% | 36,347 | +0.0% | 0.09% | +5.9% |
| Q2 2013 | $2,301,000 | – | 36,341 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |